-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly: Orfugliptide reached major and secondary endpoints in clinical trials.

Zhitongcaijing·12/18/2025 11:49:02
Listen to the news
Eli Lilly: Orfugliptide reached major and secondary endpoints in clinical trials.